Skip to content

Microbiome Changes in Travelers to Tropical Destinations

Microbiome Changes in Travelers to Tropical Destinations

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02295254
Enrollment
100
Registered
2014-11-20
Start date
2014-09-30
Completion date
2019-01-31
Last updated
2017-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal Diseases

Brief summary

The human gut contain a wide range of microorganisms creating the gut microbiome. The microbiome has great impact on metabolic and immunologic processes and responses. Travelers who travel to tropical destinations where the intestinal infection risk is high are prone to microbiome changes. During the current study the travelers will give feces specimen before and after the travel and their microbiome will be analyzed.

Detailed description

Individual differences in the microorganisms variety are affected by external factors such as food, age, geographic location, medication consumption, host genetics and exposure to microorganisms in early stages of life. During the current study the geographic location affect will be tested by comparing the microorganism environment before and after traveling to tropical destinations.

Interventions

The travelers will give feces sample before and after the travel. The sample microorganisms will be analyzed.

Sponsors

Weizmann Institute of Science
CollaboratorOTHER
Sheba Medical Center
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Travelers who intended to travel to tropical areas * Good general health

Exclusion criteria

* Medication consumption * Background diseases

Design outcomes

Primary

MeasureTime frameDescription
Type and number of intestinal microorganisms1 yearThe participants microbiome will be analyzed before and after the travel. The type and number of microorganisms will be determined by microbiological measurements.

Countries

Israel

Contacts

Primary ContactEli Schwartz, MD, DTMH
Eli.schwartz@sheba.health.gov.il

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026